Patents by Inventor Ingo Saar

Ingo Saar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250051288
    Abstract: The present invention relates to a method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione or salts thereof, to the solubilisate produced by this method and respective uses in pharmaceutical dosage forms. A phosphatidylcholine-based solubilization method is disclosed.
    Type: Application
    Filed: October 21, 2024
    Publication date: February 13, 2025
    Applicant: MetrioPharm AG
    Inventors: Ingo SAAR, Wolfgang BRYSCH, Jörg VON WEGERER
  • Patent number: 12122753
    Abstract: The present invention relates to a method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione or salts thereof, to the solubilisate produced by this method and respective uses in pharmaceutical dosage forms. A phosphatidylcholine-based solubilization method is disclosed.
    Type: Grant
    Filed: January 10, 2019
    Date of Patent: October 22, 2024
    Assignee: MetrioPharm AG
    Inventors: Ingo Saar, Wolfgang Brysch, Jörg von Wegerer
  • Publication number: 20240000877
    Abstract: A process for producing a granulate from a fermented topinambur syrup is disclosed. The product of the process is a free flowable granulate with a high content of carbohydrates such as inulin and fructooligosaccharides. Useful applications of this granulate are disclosed likewise.
    Type: Application
    Filed: October 6, 2020
    Publication date: January 4, 2024
    Applicant: Begapinol Holding GmbH
    Inventors: Ingo Saar, Marcus Heidenreich
  • Publication number: 20230210786
    Abstract: The present invention relates to a method for solubilizing phytogenic, endogenous and synthetic cannabinoids, to the solubilisate produced by this method and respective uses as a pharmaceutical dosage form. A MCT oil- and non-hydrogenated phosphatidylcholine-based solubilization method is disclosed.
    Type: Application
    Filed: June 1, 2021
    Publication date: July 6, 2023
    Inventors: Ingo SAAR, Wolfgang BRYSCH
  • Patent number: 11497760
    Abstract: The present invention relates to a method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents, to the solubilisate produced by this method and respective uses as a dietary supplement or pharmaceutical dosage form. A phosphatidylcholine-based solubilization method is disclosed.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: November 15, 2022
    Assignee: Athenion AG
    Inventors: Ingo Saar, Wolfgang Brysch, Jörg Von Wegerer
  • Patent number: 11207256
    Abstract: The present invention relates to a method for solubilizing poorly water-soluble organic cosmetic agents, to the solubilisate and cosmetic preparations produced by this method and respective uses of the solubilisate in cosmetic preparations. A phosphatidylcholine-based solubilization method is disclosed.
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: December 28, 2021
    Assignee: ATHENION AG
    Inventors: Ingo Saar, Wolfgang Brysch, Jörg von Wegerer
  • Publication number: 20210205345
    Abstract: The present invention relates to a method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents, to the solubilisate produced by this method and respective uses as a dietary supplement or pharmaceutical dosage form. A phosphatidylcholine-based solubilization method is disclosed.
    Type: Application
    Filed: August 30, 2017
    Publication date: July 8, 2021
    Applicant: ATHENION AG
    Inventors: Ingo Saar, Wolfgang Brysch, Jörg Von Wegerer
  • Publication number: 20210061771
    Abstract: The present invention relates to a method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione or salts thereof, to the solubilisate produced by this method and respective uses in pharmaceutical dosage forms. A phosphatidylcholine-based solubilization method is disclosed.
    Type: Application
    Filed: January 10, 2019
    Publication date: March 4, 2021
    Applicant: MetrioPharm AG
    Inventors: Ingo Saar, Wolfgang Brysch
  • Publication number: 20200397905
    Abstract: The present invention relates to a method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents by means of hill oil extract, to the solubilisate produced by this method and respective uses as a dietary supplement or pharmaceutical dosage form.
    Type: Application
    Filed: March 6, 2019
    Publication date: December 24, 2020
    Applicant: ID CARE UG (haftungsbeschränkt)
    Inventors: Ingo Saar, Wolfgang Brysch
  • Publication number: 20200170915
    Abstract: The present invention relates to a method for solubilizing poorly water-soluble organic cosmetic agents, to the solubilisate and cosmetic preparations produced by this method and respective uses of the solubilisate in cosmetic preparations. A phosphatidylcholine-based solubilization method is disclosed.
    Type: Application
    Filed: June 28, 2018
    Publication date: June 4, 2020
    Applicant: ATHENION AG
    Inventors: Ingo Saar, Wolfgang Brysch, Jörg Von Wegerer
  • Publication number: 20200113824
    Abstract: The present invention relates to a dispensing cap for the delivery of a fluid solubilisate, a beverage system configured for the use of such a dispensing cap and a method for preparing a beverage by means of such a beverage system. Poorly water-soluble dietary supplements or pharmaceutical active agents can be delivered in this new dosage form in order to increase the bioavailability of these substances. The solubilisate has been solubilized without a polysorbate.
    Type: Application
    Filed: April 11, 2018
    Publication date: April 16, 2020
    Applicant: ATHENION AG
    Inventors: Ekkehard Brysch, Wolfgang Brysch, Ingo Saar, Jörg Von Wegerer
  • Publication number: 20060257352
    Abstract: The invention relates to cosmetic and/or dermatological formulations containing lecithin and essential fatty acids, which ensure a maximal skin moisture supply to the skin with a simultaneous acceleration of metabolism processes, so that the healing process of damaged skin is supported.
    Type: Application
    Filed: June 22, 2005
    Publication date: November 16, 2006
    Inventor: Ingo Saar